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T-cell antigen receptors (TCR) a.re divided into common ap 
and less common yo types. In the murine skin, TCR yo+ cells 
have been reported to form the great majority of epidermal T 
lymphocytes. We have examined the relative contribution of 
TCR ap+ and TCR yo+ cells to the T-cell population in 
normal human skin. Serial sections of freshly frozen skin 
specimens were acetone fixed, incubated with anti-CD3,fiFI 
(anti-TCR ap), anti-TCR yo-I and anti-TCR 01 (anti-TCR 
yO) monoclonal antibodies (MoAb), and stained with a highly 
sensitive method. 
Over 90% of the T cells of normal human skin are local-
ized around the postcapillary venules of the dermis, while less 
than 5% are present within the epidermis. In papillary 
dermis, TCR yO+- cells formed on average 7% (anti-TCR 
yO- I) or 9% (anti-TCRol) of the total number ofCD3+ cells, 
while T C R ap+ cells constituted up to 80%. In epidermis, 
T he human intcgument harbors a wide variety of im-mune-responsc-associated cells, forming a complex-iry recently denominated the skin immune system (SIS) it]. The epidermal compartment, mainly com-posed of kcrarinocytes. contains dendritic Langer-
hans' ce lls (LC) and indeterminate cell, [2J as well as T lymphocyte, 
[3,4]' Quantitative immunophenotyping studies in vertical sections 
of normal human skin have revealed thac the mean number of CD3+ 
T c('lIs in the epidermis ex trapolated [0 10-mm section width is 8.6, 
of which the majority is CD8+ [4J. However, the great majority of 
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MoAb: monoclonal :a ntibody 
PBS: phosphate buffered saline 
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these percentages were 18% and 29% for TCR yO+- cells, and 
up to 60% for TCR ap+ cells. 
It is concluded that there is no preferential immigration or 
in situ expansion ofTCR yo+ T cells in normal human skin, 
because the relative percentages found for the TCR ap+ and 
T C R yo+ populations in skin are comparable to those found 
in lymphoid organs and peripheral blood. However, the per-
centage of TCR yO+- cells in epidermis seemed on average 
hi gher than in papillary dermis. Therefore, there may still be 
a difference in migration patterns of TCR yo+ v TCR ap+ 
cells, but this does not result in their preferential localization 
in human epidermis. The hypothesis that TCR yO+- T cells 
have a specialized function in immunosurveillance of epithe-
lia may thus not be valid for human epidermis.] blllfSt D erma-
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T lymphocytes in human skin is present in thc papillary dennis (on 
average 275 CD3+ cells per to-mm section width, evenly distrib-
uccd over the CD4+ and CDS+ subpopularions [4). These dermal T 
cells are localized mainly around the poStcapillary venules. 
Recently, two different types of T lymphocytes have been de-
fined on the basis of expression of either TCR up. responsible for 
recognition of foreign antigens in the context of molecules of the 
major histocompatibiliry complex (MHC) [5J, ocTCR yo [6J. Upon 
stimulation, human TCR yo+ cells can display cy tolytic activity 
]7,8] and/or produce Iymphokine, [9J. The majociry ofTCR yo+ 
cells desc ribed thus far exert MHC non-restricted cytolytic activity, 
which i, Iymphokine induced POJ. AI,o, TCR yo· cell, that recog-
nize allogeneic MH C molecules have been described in mouse and 
man [11-13]. However, the exact role these cells play in the im-
mune system and their naturalligand(s) is not yet defined. 
TCR }'o+ cel ls constitme on average 5% of T cells in normal 
peripheral blood and on average 1 % of CD3"~ thymocytes . with a 
wide variation between donors 110,141. The majority ofTCR yo+ 
cells arc of the CD4-S- phenotype, but dependent on the donor, 
significant percentages of C DS+ cells can be found. while CD4+ 
cel ls occur in very low frequency [10] . Similar percentages have 
been reported for TCR yo+ cells in murine peripheral lymphoid 
organs and thymus. These T C R yb'+ cells are also predominantly 
CD4-S-; however, in murine epidermis, the great majority of T 
lymphocyte, express TCR yo rather than TCR ap [15 - 19]. Such a 
si tuation is also encounrered in murine intestinal epithelium, where 
TCR yo· cells of the CD8+ phenorype ace the predominant T-cell 
population [20,21 J. These findin gs have led to the hypothe'i' that 
TCR yo· cells preferentially home into epithelia where they playa 
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role in immunosurveillancc against infections and malignant trans-
formation [21 - 23). 
TCR}, and & genes rearrange at an early stage in thymic differen· 
fiation, prior to or coinciding with p, but preceding a gene rear-
rangement r24 - 27J. In the mouse, the earliest TCR }' gene rear-
rangement event involves the V}'3 gene segment [28,29J. Cells 
expressing Vy3 are found in the early fetal thymus but are also the 
predominant T-cell population in the murine skin. From this obser-
vation it has been postulated that this first wave of thymocytes may 
home into the skin 129J. Alternatively, TCR y and & gene rearrange-
ments C.1.n also take place extrathymically as evidenced by the occur-
rence ofTCR yo+ cells in athymic mice [31-33). The site(s) where 
such differentiation takes place is unknown, but it is conceivable 
that the special epithelial microenvirollllent of the skin serves such 
a purpose. 
To test whether such hypotheses would be valid for the human 
SIS. we have quantitated the distribution ofTCR yo+ and TCR ap+-
T lymphocytes in a series of skin specimens obtained from 10 nor-
mal donors. We have employed two previously characterized 
MoAbs, reactive with all molecular forms of human TCR y& de~ 
scribed thus far [10,34), , MoAb specific for TCR OIP (35), and an 
ami~CD3 MoAb, to quantitate the reiuive contribution ofTCR ya+ 
and TCR ap+ cells to the T-cell population of normal human skin. 
MATERIALS AND METHODS 
Normal Human Skin Biopsies Biopsies were obtained with 
informed consent from clinically (confinned histologically) normal 
skin of volunteers. A total of 10 biopsies, all from the trunk, were 
studied. Tissue specimens were frozen in liquid nitrogen scored at 
-90°C until use. 
MoAb Anti-TCR YO- I MoAb (hybridoma name IIF2) detects all 
molecular forms of TCR yo described thus far [10). Anti-TCR 01 
MoAb [34) was purchased from T Cell Sciences (Cambridge, MA) 
and reacts identically with viable TCR yc5+ cells as anti· TCR Y&-l 
(unpublished observations). Both MoAb can therefore be termed 
pan-anti. TCR yt5. They were used as purified Igat 14,ug/ml and 0.3 
I'g/ml. Expression ofTCR ap was determined with the MoAb PF I 
(1: 100 dilution, T Ceil Sciences; 35). To study concurrent expres-
sion of other glycoproteins by TeR -;&+ cells of skin, serial sections 
were stained as described below with the following MoAb: anti-
CD3 (1: 50 dilution, anti-Leu-4; Becton Dickinson, Moulltain 
View, CA), anti-COB (1: 50 dilution, anti-Leu-2a; Becton Dickin-
son), and anti-CDla (I: 150 dilution, OKT6; Orrho Pharmaceuti-
cals, Raritan, NJ). 
Immunohistochemistry Different immunohistochemical tech-
niques were compared on cryoscat sections of fresh-frozen normal 
human neonatal thymus. normal human lymph node tissue. and 011 
cyrospin preparations ofTCR ya+ T-cell clones. serving as positive 
controls. The following method was selected: 6-,um thick vertical 
skin cryostat sections, fixed with fresh. pure ace cone at 4°C on 
polylysine pre-treated slides, were pre incubated in normal goat 
serum (1: 10 dilution. 10 min) and incubated successively with: -1-
MoAb diluted as described above (60 min); -2- rabbit ami mouse 
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19, (Dakopa"" Glostrup, Denmark) (1 : 25 dilution, 30 min); - 3-
alkaline phosphatase (AP) anti-AP complex (APAAP; Dakopatts) 
(1 :50 dilution, 30 min); -4- rabbit anti mouse Ig (20 min); -5-
APAAP (20 min). For negative controls. first- and second-step re-
agents were omitted. Between incub2t1ons. sections were rinsed in 
phosphate-buffered saline (PBS). AP activity was detected histoche-
mically (4): a carmine red color was developed using naphtol-AS-
MX-phosphate (Sigma Chemical Co., St. Louis, MO) as substrate 
and Fast Red Violet LB (Sigma) as azo dye. Endogenous AP activity 
was inhibited with 1 mM levanmizole (Sigma) added to the incuba-
tion medium. Nuclei were counter-st2ined by Mayers hematoxylin. 
Lymphocyte Enumeration We have determined the total num-
ber of CD3+, TCR ap, and TCR yo' lymphocytes within epi-
dennis and papillary dermis as follows: cells were detected with the 
relevant MoAb and counted in seven different sections of normal 
human skin specimens from each of the ten donors. For counting, 
skin sections were divided into suprabasal and intrabasal com part-
menes within the epidermis and into free and perivascular compart-
ments within the papillary dennis. Cell numbers thus obtained were 
extrapolated to 1 O-mm section width. Means and ranges of70 enu-
merations for each MoAb were determined. 
lmmunophenotyping of Serial Sections To determine cocx-
pression of different membrane molecules on TCR ya+ Iympho· 
cytes. seven separate sets of six serial sections of each of ten skin 
specimens were made. Serial sections were incubated with {1Fl. 
OKT6. anti-TCR yO- I. anti·Leu-4, .anti-TCR al. and anti-Leu-2a. 
in this order. In this way, expression of CD la, CD3. and COB could 
be traced back to TCRy&+ cells by comparing adjacent sections. 
RESULTS 
Enumeratio n of CD3+, TCR a{r', and TCR 'Yd+ Cells in Ver-
tical Sections of Normal Human Skin A total often different 
donors were studied. Per donor, four sets of seven different skin 
sections were made for staining with eidler .ami-CD3, anti-TCR ya 
(two differCl" MoAb), or anti-TCR ap MoAb. Only cells that 
showed plasma membrane staining were counted, because with the 
technique used, negative control PBS as well as all MoAb gave 
aspecific. weak, cytoplasmic staining of basal keratinocytes. T cells 
were enumerated as present in various comrartments of human skin 
thought to reflect different sites for T-cel migration from an imp 
munodynamical point of view r36]. Mean numbers and ranges of 
positive cells present in the different skin compartments, as well as 
in epidermis and papillary dermis as a whole, are given in Table I. 
The mean number of CD3+ cells detected per 10 mm total skin 
section width was 267.97 (Table 1). which is consistent with the 
number we have reported previously [4J. The great majority of skin 
T lymphocytes is located in the papillary dermis. rather than in the 
epidermis, and particularly at perivascular si tes. The reticular dermis 
also contains a substantial number of T cells. which we have nOt 
determined here, but which were 164.05 on average. according to 
our previous study [4J. Therefore, we can conclude [hat CD3+ cells 
present in epidermis form less than 2% of toral number ofT cells in 
normal human skin. 
Table 1. Mean Numbers and Ranges of Total T cells and TCR a/f" and TCR)'<5+ Subpopulations Present Per Vertical Section of 
10-mm Width at Different Sites Within Normal Human Skin 
Epidermis Papill;uy Dermis 
Suprabasal Intrahas21 Free Perivascular Total 
CD3+ 0.72 5.71 20.99 247.07 267.97 
(anri.Lcu4) 0.00- 11.72 0.00 - 52.94 0.00 - 95.00 23.73 - 780.00 25.42-88 1.58 
TCRa/l' 0.36 3.48 11.63 201.90 216.83 
(/iFI) 0.00- 7.02 0.00 - 27.69 0.00 - 45.22 62.86- 747.69 62.86-815.38 
TCR yJ+ 0.10 1.09 2.03 15.96 19.10 
(,nti-TCR yJ-I) 0.00 - 4.44 0.00 - 7.41 0.00 - 16.17 0.00 - 111.43 0.00-125.71 
TCR Yd+ 0.29 1.56 2.64 20.72 25.15 
(TCRdI) 0.00- 11.11 0.00 - 15.79 0.00-25.64 0.00 - 133.33 0.00-171.79 
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Table 11. Percentages of CD3+ Lymphocytes in Normal 
Human Slcin Expressing TCR afJ or TCR .,J (CD3+ = 100%)' 
TCR ",p TCR y.; TCR yo 
(/lFI) (anti-TCR yO-I) (TCROI) 
Epidermis 60% 18% 29% 
Suprabas.al 50% 14% 40% 
InrrabaSlI 61% 19% 27% 
Papillary Dermis 80% 7% 9% 
Frroro 55% 10% 13% 
Perivascular 82% 7% 8% 
Toral 81% 7% 9% 
• Cllcul,lIcd from Tlbl~ I. 
Table II gives the percentages of CD3+ cells expressing TCR ClP 
or TCR yo in the various skin compartments as calculated from the 
numbers given in Table J. Clearly, the great majority ofT lympho-
cytes of normal human skin at whatever location, express TCR ap 
rather than TCR )10. Depending on the MoAb used, either anti-
TCR y6-1 or anti-TCR 01. the percentages of TCR yo+ cells in 
epidermis were IB% or 29%, respectively. Figure ta1b give an im-
pression of the localization and morphology of these TCR yo ex-
pressing cells in the epidermis (intrabasal and suprabaS3I, respec-
tively). Within the epidermis. TCR yo+ cells often displayed a 
slightly dendritic morphology. Within the papillary dermis. TCR 
yo+ cells formed 7% or 8% of perivascular T cells and 10% or 13% 
ofless common free T cells (again depending on the MoAb used). At 
these sites, TCR yo+ cells always had a typical lymphoid appearance. 
Although Tell. yc5+ cells were never the predominant T Iympho-
A 
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cyte type at any location in the skin, the epidermis contained rela-
tively more TCR yc5+ cells than the papillary dennis. 
Phenotype afTeR ya+ Lymphocytes as Determined in Serial 
Sections Double staining techniques were unsatisfactory to deter-
mine coexprcssion of various antigens with TCR yo, mainly because 
of the low frequency. but particularly because of the widely varying 
number of TCn. yo+ cells present in different sections. In many 
sections. no TCR yo+ cells could be detected (see ranges in Table I). 
Therefore, we could not reliably interpret staining specificity on 
skin sections, although this was satisfactory on t 00% positive TCR 
y&+ T-cell clones serving as positive controls. 
For these reasons, we have employed the serial section approach . 
Anri-CD3 staining on TCR ya+ cells was checked as a specificity 
control, because the TCR requires CD3 for cell-surface expression 
and should therefore always be coexpressed with this molecular 
complex [37J. T C R yo+ cells, especially when present in small clus-
ters, could be tnced back in adjacent sections stained with anri-
CD3. We have no evidence that Tell. yo staining occurred in the 
absence of anti-CD3 staining. 
The majority ofTeR )10+ cells present in human peripheral blood 
have the CD4-8- phenotype, but a varying proportion express 
COB, depending on the donor. Murine dendritic epidermal TCR 
yd+ are also double negative r 19J. but intestinal epithelial TCR yo+ 
cells have been shown to express predominantly COB, and have 
been postulated to constitute a particular subset of TeR yo+ cells 
[20,21 J. For this reason we were interested in studying coexpression 
of CD8 with TCR yo in human skin. Only epidermal T cells were 
studied because the high frequency of CD8+ TCR Cl.p+ cells in 
papillary dermis made interpretation of serial sections impractical. 
-
B 
Figure 1. TCR yo expressing cells in vertical section of normal human skin. These cells were mosrly localized intr:lbasally (a) or directly suprab~1 (b) in the 
spinal layror of epidermis (original magnification 400 X). 
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Within epidermis no CD8+ cells were detected in the same location 
as anti-TCR 01+ cells in adjacem sections. 
In LC enriched epidermal cell suspensions we observed occa-
sional cytoplasmic. but no plasma membrane staining with the (wo 
different anti~ TCR yo MoAb as intact antibodies as well as F(ab' h 
fragmems (38 and unpublished). Therefore, we were curious to 
know whether epidermal TCR yo+ cells also showed re2ctivity with 
anri~COla and MoAb in tissue sections. Occasional epidermal cells 
displaying extensive dendritic morphology stained in serial sections 
with anti-COla as well as with anti-TCR yo MoAb. It remains to be 
determined whether this points towards a relationship between LC 
and TCR yo+ cells or it is a staining artifact. 
DISCUSSION 
Since 1982. several laboratories have reported the presence of 
Thy-I+ dendritic epidermal cells (DEC) in normal mOuse epidermis 
[39 - 42). The Thy-I marker is not T-cell specific, because i, is also 
expressed in mouse brain. However. murine DEC were defined as 
belonging to the T -cell lineage because they reacted with antibody 
to the CD3 molecular complex. Next. it was shown that murine 
DEC predominantly express CD3 in associ.uion with the alterna-
tive TCR yo, rather than the common TCR ClP. expressed on maS{ 
peripheral T cells [15-19). Because it became apparent that DEC 
were a special intra-epithelial and dendritic population of T lym-
phocytes, they have been renamed dendritic epidermal T cells 
(DETC) [19). Two extensive searches for the human analogue of 
murine Thy-I+ DETC were unsuccessful [3,43J, which was per-
haps due to the fact that in man the Thy-l marker is not expressed 
on bone marrow-derived cdls bur only in rhe brain [441. Recently, 
MoAb directed against human TCR 1'0 have become available. This 
has made it possible to reinvestigate rhe existence of a human ana-
logue of DETC. We have stained a number of normal human skin 
sections obtained from 10 adult donors with these anti-TCR yo 
MoAb. 
Within the epidermis. TCn. yo+ cells formed a minority ofinrra-
epithelial T lymphocytes. Depending on the MoAb used. percent-
ages as expressed in relation to the total mean number of CD3+ cells 
varied and constituted 18% and 29%, respectively, for anti-TCR 
y<i-I and anti-TCR 01 (Table II). TCR apt cells made up 60% of 
intra-epidennal CD3+ cells. The majority of the intra-epidermal 
TeR yo+ lymphocytes were localized in the basal layer. which does 
nOt differ essentially from the localization ofTeR ClP+ cells within 
the epidermis (Table I). The wide range in numbers afTCR yo+ as 
well as TCIt ClP+ cells as expressed per IO-mm epidermal section 
widt.h, is in accordance with the observation that intra-epidermal T 
lymphocytes occur in clusters [45). In the epidermis, TCR yo+ cells 
often showed a slightly dendritic morphology (Fig la,b), presum-
ably because they are localized between kcratinocytes that are 
known to have extensive intercellular adhesion structures. Occa-
sionally, TCR yo+ cells with highly dendritic morphology were 
observed, especially within hair follicle epithelium. In serial sec-
tions, these rare, highly dendritic TCR yo+ cells also expressed 
CDla. 
In the dermis. TeR )'0+ cells formed, again depending on the 
MoAb used, 7% or 9% of the mean number of C03+ cells counted 
in adjacent sections. TCR a.p+' constituted 80% of dermal CD3+ 
cells (Table II). As expected in view of our previous study of the 
distribution of CD3+ cells in normal human skin [4 J, the majority of 
both TCR a.pr and TCR ,/0+ cells were present around the post-cap-
illary venule'S. The wide range of both subsets at these perivascular 
sites (Table I) can be explained by the observation that clusters of 
dermal T cells arc found around some but not all post-capillary 
venule. (unpublished). The morphology of dennal TCR yo+ T cells 
was lymphoid, i.e. , round snull cells with clearly stained plasma 
membranes. 
Two inconsistencies are obvious from Tables I and II. In the first 
place, there is a discrepancy between the number and percentages of 
TCR yo+ cells detected with the two different MoAb. Anti-TCR 
'/0-1 and anti-TCR 01 are conspicuous when low numbers of lym-
phocytes are counted. such as in epidermis. but even out when total 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
skin lymphocytes are considered. Second, the sum ofTeR yo+ and 
TCR apt cells did not reach 100% of CD3+ cells. Both anti-TCR 
yJ MoAb stain exactly comparable percentage of cells in unsepar-
ated preparations of viable lymphocytes and perform identica.lly 
when tested on viable TCR yo+ clones in immunofluorescence 
U.J .M. van Dongen .nd J. 80"" submitted). Therefore, the dis-
crepancies found here may reflect differences in the reactivity of the 
MoAb on acetone-fixed tissue. The same problem may playa role in 
the detection ofTCR apt cells wi,h fJFI MoAb. 
It is difficult to understand that LC may express TeR yo, which is 
suggested by our observations (38) and by those of other investiga-
tors [45). As reported here, highly dendritic epidermal cells, which 
reacted with anti-TCR yO' MoAb as well as with anti-CD 1 a in 
adjacent sections. have been found in occasional tissue sections. In 
addition, over 10% of CO la-positive cells in LC enriched human 
epidermal cell suspensions showed reactivity with anti-TCR yo 
MoAb. This was observed only in cytospin prepaf2tions of acetone 
fixed, penneabilized ceJls, but not in suspensions of viable cells, 
indicating that reactivity occurred with cytoplasmic components. 
This reactivity was observed with anti-TCR )'0-1 in the fonn of 
intact Ig, as well as F(ab' h fragments, and with anti-TCR 01, anti-
TiyA [13), and orcs I MoAbs [14J, while negative controls were 
satisfactory (M.B.M. Teunissen, unpublished). The possible expres-
sion of Tcn yo in LC is puzzling, particularly in view of the fact 
that until now. no CD3 expression has been observed on dlese cells, 
while it is known that CD3 expression is an obligate requirement 
for TCR expression {37]. The option that human LC would contain 
molecules homologous or identical to TCR Yd (exclusively in the 
cytoplasm) clearly needs further investigation. 
In conclusion. our findings suggest that with respect to their 
distribution within normal human skin TCR yo+ T cells behave 
analogous to TCR apt T cells. TCR yo+ lymphocytes arc m.inly 
localized around the post-capillary venules and consti tute about 8% 
of rhe total mean number of CD3+ T cells in normal human skin 
(Table II ). This ratio is comparable to that found in peripheral blood 
and lymphoid organs [10,14,45]. However, within the epidermis, 
TCR yt5+ cells formed a slightly higher percentage of to[al T cells 
than in the dermis. Therefore, there may be a difference in migra-
tion pattern ofTCR )'0+ cells v TCR o.{r cells into the epidermis, 
b.ut this does nOt result in a predominance of TCR )'0+ cells at this 
Site. 
The situation in adult human skin thus seems to be substantially 
different from that described for murine skin. A human analogue for 
the murine DETC has not been identified as such, with regard to 
numbers, distribution, and morphology. Future studies, especially 
into the ontogeny of the T cells of SIS, might reveal whether at an 
earlier point in human development there is a situation comparable 
to that observed in the mouse. Preliminary studies have not revealed 
higher percentages ofTCR )'0+ cells in human neonatal skin than in 
adult skin (T. Vroom et al., in preparation). 
Given rhe cytotOxic potential ofTCR yo+ cells and their presence 
in murine epithdia. it has been hypothesized that TCR yo express-
ing cells may playa role in continuous immune surveillance of 
epithelia [21-23]. If onc would solely take into consideration the 
relative number of human epidermal T cells expressing TCR yO', 
their frequency would argue against such a function in man. How-
ever, analysis of ligand specificity, proliferative responses to anti-
genic stimuli and/or Iymphokines. and effector functions ofTCR 
yo+ epidermal cells will reveal whether both T-cell subsets play 
similar or supplememary roles in the immunophysiology and im-
munopathology of SIS. 
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